RHB PART
Live / Registered — Registered (as of 10 Jun 2025)
What this means for you
Registered since 10 Jun 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79358374
- Registration number
- 7821159
- Mark type
- Design + words
- Filed
- 29 Jul 2022
- Published for opposition
- 21 May 2024
- Registered
- 10 Jun 2025
- Attorney of record
- Haverly MacArthur
Goods and services
- Class 001 — Chemicals: Biological preparations for industrial use in manufacture; biological preparations for use in industry; nucleic recombinant acids, other than for medical and veterinary purposes
- Class 005 — Pharmaceuticals: Biotechnological preparations for medical use for the treatment of infectious and parasitic diseases, neoplasms, cancer, diseases of the blood and blood-forming organs, immune disorders, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye, diseases of the ear, diseases of the cardiovascular, respiratory, genitourinary, and digestive systems, diseases and conditions of the skin and subcutaneous tissue and the musculoskeletal system and connective tissue, conditions relating to pregnancy, childbirth and the puerperium, conditions originating in the perinatal period, congenital malformations, deformations and chromosomal abnormalities, and poisoning; biotechnological preparations for medical purposes for the treatment of infectious and parasitic diseases, neoplasms, cancer, diseases of the blood and blood-forming organs, immune disorders, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye, diseases of the ear, diseases of the cardiovascular, respiratory, genitourinary, and digestive systems, diseases and conditions of the skin and subcutaneous tissue and the musculoskeletal system and connective tissue, conditions relating to pregnancy, childbirth and the puerperium, conditions originating in the perinatal period, congenital malformations, deformations and chromosomal abnormalities, and poisoning; biotechnological preparations, namely, nucleic recombinant acids for medical use
- Class 042 — Scientific and technological services: Biotechnological research; testing of biological reagents for use in molecular biology
Owner
Prosecution history
- 22 Jan 2026 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 07 Jan 2026 — FINAL DISPOSITION NOTICE SENT TO IB
- 07 Jan 2026 — FINAL DISPOSITION PROCESSED
- 10 Sept 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 10 Jun 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Jun 2025 — REGISTERED-PRINCIPAL REGISTER
- 30 Jun 2024 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 07 Jun 2024 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 07 Jun 2024 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 27 May 2024 — NOTIFICATION PROCESSED BY IB
- 21 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 May 2024 — PUBLISHED FOR OPPOSITION
- 08 May 2024 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 08 May 2024 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 01 May 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED